LanzaTech Global Inc (LNZA)

NASDAQIndustrialsWaste ManagementSnapshot 2026-10-23

$4.81-3.41%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge LanzaTech Global Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$8M–$11M	—
Operating expenses	$13M–$17M	—
FY 2026 · Q4
Revenue	—	15.2M
EPS	—	-0.94
FY 2026 · Annual
Revenue	$50M–$55M	54.2M
EPS	—	-3.73
Operating expenses	$51M–$55M	—

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Operating loss reduction to less than $10 million	A primary condition in LanzaTech Global Inc's published investment case. The stated target is operating loss <= $10 million.	Broken	operating loss worsens beyond -$15 million in FY26	Operating income: $-9.873M FY2026-Q2; GAAP. Published target: operating loss <= $10 million. Target period is not explicitly aligned with this observation. Source published Aug 14, 2026-9,873,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1014ad1c-a7c1-4f65-8ce9-8d9e4a5f799f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth of at least 30% year-over-year	A primary condition in LanzaTech Global Inc's published investment case. The stated target is >=30% YoY revenue growth.	Intact	YoY revenue growth falls below 20% in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Revenue increased from $9.5 million in 2025-Q1 to $12.0 million in 2026-Q1, driven by higher engineering services revenue from new projects. However, revenue was flat at about $9.0 million in 2026-Q2 compared to 2025-Q2. The trajectory shows delivering growth in early 2026 but stagnation in Q2 2026. Delivery assessment Oct 24, 2026
Successful development of Shougang LanzaTech joint venture	The joint venture Shougang LanzaTech completed a positive IPO, showing growth potential.	Intact	JV market value declines significantly or partnership dissolves	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. The Shougang LanzaTech JV completed its IPO in June 2026, raising approximately US$75 million with LanzaTech retaining 8.38% equity post-IPO, down from 9.31% pre-IPO. This milestone validates LanzaTech's strategy of combining technology licensing with equity participation in commercial projects. The trajectory shows delivering on this strategic partnership priority. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · alphavantage

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · alphavantage
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-06-10	Unavailable	Unavailable	— / 0
2026-06-11	Unavailable	Unavailable	— / 0
2026-06-12	Unavailable	Unavailable	— / 0
2026-06-13	Unavailable	Unavailable	— / 0
2026-06-15	Unavailable	Unavailable	— / 0
2026-06-17	Unavailable	Unavailable	— / 0
2026-06-18	Unavailable	Unavailable	— / 0
2026-06-20	Unavailable	Unavailable	— / 0
2026-06-21	Unavailable	Unavailable	— / 0
2026-06-25	Unavailable	Unavailable	— / 0
2026-06-27	Unavailable	Unavailable	— / 0
2026-06-28	Unavailable	Unavailable	— / 0
2026-06-29	Unavailable	Unavailable	— / 0
2026-06-30	Unavailable	Unavailable	— / 0
2026-07-01	Unavailable	Unavailable	— / 0
2026-07-02	Unavailable	Unavailable	— / 0
2026-07-03	Unavailable	Unavailable	— / 0
2026-07-04	Unavailable	Unavailable	— / 0
2026-07-05	Unavailable	Unavailable	— / 0
2026-07-07	Unavailable	Unavailable	— / 0
2026-07-31	Unavailable	Unavailable	— / 0
2026-08-04	Unavailable	Unavailable	— / 0
2026-08-08	Unavailable	Unavailable	— / 0
2026-08-09	Unavailable	Unavailable	— / 0
2026-08-12	Unavailable	Unavailable	— / 0
2026-08-14	Unavailable	Unavailable	— / 0
2026-08-15	Unavailable	Unavailable	— / 0
2026-08-16	Unavailable	Unavailable	— / 0
2026-08-17	Unavailable	Unavailable	— / 0
2026-08-18	Unavailable	Unavailable	— / 0
2026-08-19	Unavailable	Unavailable	— / 0
2026-08-20	Unavailable	Unavailable	— / 0
2026-08-21	Unavailable	Unavailable	— / 0
2026-08-22	Unavailable	Unavailable	— / 0
2026-08-23	Unavailable	Unavailable	— / 0
2026-08-24	Unavailable	Unavailable	— / 0
2026-08-25	Unavailable	Unavailable	— / 0
2026-08-26	Unavailable	Unavailable	— / 0
2026-08-27	Unavailable	Unavailable	— / 0
2026-08-28	Unavailable	Unavailable	— / 0
2026-08-29	Unavailable	Unavailable	— / 0
2026-08-30	Unavailable	Unavailable	— / 0
2026-08-31	Unavailable	Unavailable	— / 0
2026-09-01	Unavailable	Unavailable	— / 0
2026-09-02	Unavailable	Unavailable	— / 0
2026-09-03	Unavailable	Unavailable	— / 0
2026-09-04	Unavailable	Unavailable	— / 0
2026-09-05	Unavailable	Unavailable	— / 0
2026-09-06	Unavailable	Unavailable	— / 0
2026-09-07	Unavailable	Unavailable	— / 0
2026-09-08	Unavailable	Unavailable	— / 0
2026-09-09	Unavailable	Unavailable	— / 0
2026-09-10	Unavailable	Unavailable	— / 0
2026-09-11	Unavailable	Unavailable	— / 0
2026-09-12	Unavailable	Unavailable	— / 0
2026-09-13	Unavailable	Unavailable	— / 0
2026-09-14	Unavailable	Unavailable	— / 0
2026-09-15	Unavailable	Unavailable	— / 0
2026-09-16	Unavailable	Unavailable	— / 0
2026-09-17	Unavailable	Unavailable	— / 0
2026-09-18	Unavailable	Unavailable	— / 0
2026-09-19	Unavailable	Unavailable	— / 0
2026-09-20	Unavailable	Unavailable	— / 0
2026-09-21	Unavailable	Unavailable	— / 0
2026-09-22	Unavailable	Unavailable	— / 0
2026-09-23	Unavailable	Unavailable	— / 0
2026-09-24	Unavailable	Unavailable	— / 0
2026-09-25	Unavailable	Unavailable	— / 0
2026-09-26	Unavailable	Unavailable	— / 0

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	0	1	0
2026-06-01	0	1	0
2026-07-01	0	1	0
2026-08-01	0	1	0
2026-09-01	0	1	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Operating loss reduction to less than $10 millionPublished status: Broken
Revenue growth of at least 30% year-over-yearDirect metric needs a verified mapping
Successful development of Shougang LanzaTech joint ventureDirect metric needs a verified mapping

Next proof point

Nov 18, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.1%Typical daily move · historical

Downside history

-89.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

LanzaTech Global Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a speculative, loss-making business with a turnaround element, rather than a proven durable compounder. Its thesis is on watch: execution has advanced on the Shougang partnership and cost control, but recent results remain weak and confidence is medium.

What's priced into LanzaTech Global Inc

The evidence describes LNZA as cheap versus peers, but confidence in that valuation view is low. The discount appears consistent with weak performance, high risk, and volatile management; the evidence does not specify what operating expectations are already embedded.

What the fundamentals likely do

Near term, erratic results and a 53% estimated miss probability make the next earnings report an important risk point, and a guidance cut would be a negative signal. Across the multi-year thesis, lower operating expenses and the completed Shougang JV IPO show progress, but revenue stagnated in 2026-Q2 and operating income remains negative.

What LanzaTech Global Inc hinges on

The thesis depends on whether cost reductions translate into sustained improvement while revenue grows beyond the early-2026 increase. Near-term guidance is a key swing factor; sector bellwethers’ results may also indicate whether the Industrials tailwind supporting LNZA persists.